Clinical Research Directory
Browse clinical research sites, groups, and studies.
Internal Mammary Node Irradiation After Neoadjuvant Systemic Therapy for Breast Cancer
Sponsor: Mahidol University
Summary
This multicenter randomized controlled trial evaluates whether internal mammary node irradiation (IMNI) improves oncologic outcomes in patients with breast cancer who have residual pathologically positive lymph nodes after neoadjuvant systemic therapy. Eligible participants will be randomly assigned in a 1:1 ratio to receive locoregional radiotherapy either with or without irradiation of the internal mammary lymph nodes. The primary outcome is disease-free survival. Secondary outcomes include overall survival, breast cancer mortality, locoregional recurrence-free survival, distant metastasis-free survival, and treatment-related toxicity, particularly cardiac and pulmonary toxicity. A total of 1,760 participants are planned to be enrolled across multiple centers in Thailand.
Official title: Internal Mammary Node Irradiation Versus Omission of Internal Mammary Node Irradiation in Breast Cancer Treated With Neoadjuvant Systemic Therapy: A Phase III Multicenter Randomized Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1760
Start Date
2027-07-01
Completion Date
2036-07-01
Last Updated
2026-11-13
Healthy Volunteers
No
Conditions
Interventions
Locoregional Radiotherapy With Internal Mammary Node Irradiation
Adjuvant locoregional radiotherapy to the breast or chest wall and regional lymph nodes, including the internal mammary lymph nodes. Allowed dose-fractionation schedules include 50 Gy in 25 fractions, 42.5 Gy in 16 fractions, or 40 Gy in 15 fractions, according to the study protocol.
Locoregional Radiotherapy Without Internal Mammary Node Irradiation
Adjuvant locoregional radiotherapy to the breast or chest wall and regional lymph nodes, with intentional omission of the internal mammary lymph nodes. Allowed dose-fractionation schedules include 50 Gy in 25 fractions, 42.5 Gy in 16 fractions, or 40 Gy in 15 fractions, according to the study protocol.
Locations (9)
Siriraj Hospital
Bangkok, Bangkok Noi, Thailand
Chulabhorn Hospital
Bangkok, Thailand
Chonburi Cancer Hospital
Chon Buri, Thailand
Vibharam Amata Nakorn Cancer Hospital
Chon Buri, Thailand
Lop Buri Cancer Hospital
Lopburi, Thailand
Synphaet Hospital Nakhon Pathom
Nakhon Pathom, Thailand
Maharaj Nakhon Si Thammarat Hospital
Nakhon Si Thammarat, Thailand
Ratchaburi Hospital
Ratchaburi, Thailand
Metropolitan Hospital Tha Chalom, Samut Sakhon Hospital
Samut Sakhon, Thailand